Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994431 · ClinicalTrials.gov registry record · Phase 4
Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin
A Phase 4 study, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- Phase 4
- Development phase
- 109
- Enrollment target
NCT04994431 is a Phase 4 study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 109 participants.
The verdict
NCT04994431, a Phase 4 study, was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 109 participants
- Enrollment target
Study Summary
Post-Operative Urinary Retention (POUR) in Thoracic Surgery is a prospective interventional study aiming to test the hypothesis that the prophylactic use of tamsulosin prior to thoracic surgery in high risk patients leads to reduce the rates of POUR.
Interventions
- DRUG Tamsulosin Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2023-10-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04994431
The ClinicalTrials.gov registry entry for NCT04994431 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tamsulosin Hydrochloride is the first listed.
NCT04994431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04994431 about?
NCT04994431 is a clinical study titled "Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin". Post-Operative Urinary Retention (POUR) in Thoracic Surgery is a prospective interventional study aiming to test the hypothesis that the prophylactic use of tamsulosin prior to thoracic surgery in high risk patients leads to reduce the rates of POUR.
What is the current status of trial NCT04994431?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 109 participants. The study started on 2021-08-01. Estimated completion is 2023-10-04.
What interventions are being tested in trial NCT04994431?
The interventions under investigation include: Tamsulosin Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT04994431?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.